NCT04132466View on ClinicalTrials.gov

ASSURE WCD Clinical Evaluation - Conversion Efficacy Study

NACompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

November 25, 2019

Primary Completion Date

March 19, 2020

Study Completion Date

March 19, 2020

Conditions
Death, Sudden, Cardiac
Interventions
DEVICE

Defibrillation using the ASSURE wearable cardioverter defibrillator therapy delivered via a waveform delivery test system

defibrillation using a 170 joule biphasic truncated exponential waveform designed for the ASSURE wearable cardioverter defibrillator

Trial Locations (4)

48109

University of Michigan, Ann Arbor

63110

Washington University St Louis, St Louis

98405

Institute for Research and Innovation MultiCare Health System, Tacoma

99508

Alaska Cardiovascular Research Foundation, Inc., Anchorage

Sponsors
All Listed Sponsors
collaborator

Regulatory and Clinical Research Institute Inc

OTHER

lead

Kestra Medical Technologies, Inc.

INDUSTRY